D. Carnegie & Co invites to an audiocast in connection with publication of the second quarterly report 2017

D. Carnegie & Co AB (publ) – listed on Nasdaq Stockholm – invites to an audiocast at 10.00 am on 14 July in connection with the publication of its second quarterly report 2017, which will be published that day at 7.00 am.

Shareholders, analysts and other interested parties are welcome to participate in an audiocast in which the financial report for the second quarter will be presented by CEO Ulf Nilsson and CFO Per-Axel Sundström. The presentation and related material will be accessible through www.dcarnegie.se and can be followed via web or by telephone on the numbers provided below. Kindly call approximately five minutes before the scheduled start time so that the conference can begin punctually.

Following the presentation, conference participants will be given an opportunity to ask questions to the company’s CEO and CFO.

Numbers to the telephone conference: 

SWE: + 46 8 5664 2666 

Or

UK: + 44 20 3008 9807

Link to audiocast:

https://tv.streamfabriken.com/d-carnegie-q2-2017

This information was released for publication at 4:00 pm CEST on 10 July 2017.

About D. Carnegie & Co

D. Carnegie & Co is a property company focusing on residential properties in the Greater Stockholm region and other growth areas. The company’s business concept is to own property portfolios slated for a gradual renovation of apartments in conjunction with the natural turnover of tenants. This can take place quickly and cost-efficiently thanks to extensive experience from the company's renovation method which, among other things, means that no evacuation needs to take place. In addition to this, the company creates value through the development of building rights in existing portfolios. The market value of the company’s properties amounted to SEK17,481 million on 31 March 2017. The total rental value amounted to SEK 1,390 million annually on 31 March 2017. The economic occupancy rate is high – vacancies are virtually non-existent. D. Carnegie & Co is listed on Nasdaq Stockholm.